Mesenchymal stem cell-derived exosome microRNA as therapy for cardiac ischemic injury - 09/10/21
pages | 11 |
Iconographies | 6 |
Vidéos | 0 |
Autres | 0 |
Abstract |
Cardiovascular diseases (CVD) are a significant cause of human health harm. In the past, stem cell therapy was reported to have functional defects, such as immune rejection, tumorigenicity, and infusion toxicity. Exosomes are extracellular vesicles with lipid bilayer membrane structure, containing proteins, lipids, mRNA, miRNA, DNA, and other molecules, which can mediate various biological functions such as immune response, inflammatory response, cell migration, and differentiation intercellular communication. Exosomal miRNAs have outstanding advantages in disease diagnosis and curative effect prediction. Likewise, paracrine factors could also mediate the main therapeutic effect of mesenchymal stem cells. Research has shown that mesenchymal stem cell-derived micro-exosomes, which may come from stem cells, accumulate in the ischemic tissue and regulate cell proliferation, apoptosis, inflammation, and angiogenesis sites of myocardial injury after being transplanted. This review reviewed the molecular mechanisms of exosomes and internal microRNAs derived from mesenchymal stem cells in cardiac ischemic injury repair.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | Biogenesis in cardiac protective exosomes derived from MSCs. |
• | Cardiomyocytes and exosome miRNAs. |
• | Non-cardiac cells and exosome miRNAs. |
Keywords : Exosomes, MicroRNA, Molecular mechanism, Ischemic heart disease
Plan
Vol 143
Article 112118- novembre 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?